Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants

Part of paid clinical trials in Piscataway, New Jersey.

Sponsor
Amivas Inc.
Study ID
NCT05285735
Status
Recruiting
Apply to this trial

Conditions

  • Malaria
  • Pregnancy

Eligibility Criteria

Sex
FEMALE
Age
15 Years - 100 Years
Healthy Volunteers
Not accepted

Study Details

This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.

Key Dates

Start date
Jun 8, 2022
Status verified
Jan 2024
Primary completion
Jun 8, 2029
Completion
Jul 1, 2029

Study Design

Enrollment
25 participants (estimated)

Primary Outcome Measure

Number of pregnant females with high blood pressure [ Time Frame: Through study completion, an average of 40 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
4C Pharma SolutionsPiscatawayNew Jersey08854
Ankur Joshi
[email protected]
732-529-6989

Find similar trials in Piscataway, NJ

By research site
4C Pharma Solutions· Piscataway, NJ

Related Studies